PMID: 16523591Mar 10, 2006Paper

Tumor necrosis factor-alpha and CD40L modulate cell surface morphology and induce aggregation in Ramos Burkitt's lymphoma cells

Leukemia & Lymphoma
Reuven LaskovMarshall S Horwitz

Abstract

Interaction of CD40L and its cognate receptor is an essential component of B-lymphocyte signaling, affecting various aspects of B-cell differentiation pathways and immunoglobulin gene expression. However, much less is known about the biological consequences of B-cell signaling through tumor necrosis factor (TNF)-alpha and its cognate receptors TNF-R1 and 2. We used Ramos Burkitt's lymphoma cell line as a model system to study the direct effects of these cytokines on B cells. Treatment of Ramos cells with either TNF-alpha or CD40L, but not with interleukin (IL)- 4, interferon (IFN)-gamma and transforming growth factor (TGF)-beta, resulted in enhanced cell aggregation and enhancement of adherence to glass cover-slips. Scanning electron microscopy showed that Ramos cells have a polarized cell surface morphology and exhibit at least 3 cell surface morphological domains: microvilli, filopodia and ruffled membranes. The cells adhered to the glass matrix through multiple filopodia/podopodia-like cell processes and demonstrated distinct ruffled-like membrane projections on their opposite pole. Induction by TNF-alpha or CD40L, but not with IL-4, IFN-gamma and TGF-beta, resulted in increased number and complexity of both types of membran...Continue Reading

References

Jan 1, 1978·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·A Polliack
Jul 1, 1979·Scandinavian Journal of Haematology·J JansenR van Furth
Sep 1, 1987·The Journal of Experimental Medicine·J H KehrlA S Fauci
Nov 1, 1994·The Journal of Experimental Medicine·B R RenshawC R Maliszewski
Jan 1, 1994·Annual Review of Immunology·I C MacLennan
Jan 1, 1993·Annales Françaises D'anesthèsie Et De Rèanimation·H YsselJ E de Vries
Apr 5, 1996·Science·E C Butcher, L J Picker
Feb 9, 1996·Cell·T J Mitchison, L P Cramer
Jan 1, 1996·Advances in Immunology·C Van Kooten, J Banchereau
Jan 1, 1997·Immunity·S DenépouxS Lebecque
Jun 1, 1997·British Journal of Haematology·J BurthemJ C Cawley
Nov 14, 1997·The Journal of Experimental Medicine·D CoxS Greenberg
Oct 23, 1998·The Journal of Experimental Medicine·M C CookA Basten
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·H H LeeG Cheng
Jun 8, 1999·Annual Review of Immunology·D WallachM P Boldin
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G J Inman, M J Allday
Sep 7, 2001·Current Opinion in Immunology·A Durandy, T Honjo
Dec 19, 2001·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Wiebke MöbiusJan W Slot
Mar 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ben A CrokerAndrew W Roberts
Jun 12, 2003·Current Opinion in Hematology·Grant R GoodmanAlan Saven
Jun 26, 2003·Reviews in Clinical and Experimental Hematology·Aaron Polliack

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.